124 related articles for article (PubMed ID: 24529556)
1. Neural stem cells producing an inducible and soluble form of Gas1 target and inhibit intracranial glioma growth.
López-Ornelas A; Vergara P; Segovia J
Cytotherapy; 2014 Jul; 16(7):1011-23. PubMed ID: 24529556
[TBL] [Abstract][Full Text] [Related]
2. Lentiviral transfer of an inducible transgene expressing a soluble form of Gas1 causes glioma cell arrest, apoptosis and inhibits tumor growth.
López-Ornelas A; Mejía-Castillo T; Vergara P; Segovia J
Cancer Gene Ther; 2011 Feb; 18(2):87-99. PubMed ID: 20885451
[TBL] [Abstract][Full Text] [Related]
3. Additive effects of the combined expression of soluble forms of GAS1 and PTEN inhibiting glioblastoma growth.
Sánchez-Hernández L; Hernández-Soto J; Vergara P; González RO; Segovia J
Gene Ther; 2018 Sep; 25(6):439-449. PubMed ID: 29941984
[TBL] [Abstract][Full Text] [Related]
4. A soluble form of GAS1 inhibits tumor growth and angiogenesis in a triple negative breast cancer model.
Jiménez A; López-Ornelas A; Estudillo E; González-Mariscal L; González RO; Segovia J
Exp Cell Res; 2014 Oct; 327(2):307-17. PubMed ID: 24992044
[TBL] [Abstract][Full Text] [Related]
5. The systemic administration of neural stem cells expressing an inducible and soluble form of growth arrest specific 1 inhibits mammary gland tumor growth and the formation of metastases.
Romero-Trejo D; Mejía-Rodríguez R; Sierra-Mondragón E; Navarrete A; Pérez-Tapia M; González RO; Segovia J
Cytotherapy; 2021 Mar; 23(3):223-235. PubMed ID: 33168454
[TBL] [Abstract][Full Text] [Related]
6. Developing Bioinspired Three-Dimensional Models of Brain Cancer to Evaluate Tumor-Homing Neural Stem Cell Therapy.
Carey-Ewend AG; Hagler SB; Bomba HN; Goetz MJ; Bago JR; Hingtgen SD
Tissue Eng Part A; 2021 Jul; 27(13-14):857-866. PubMed ID: 32907497
[TBL] [Abstract][Full Text] [Related]
7. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas.
Aboody KS; Brown A; Rainov NG; Bower KA; Liu S; Yang W; Small JE; Herrlinger U; Ourednik V; Black PM; Breakefield XO; Snyder EY
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12846-51. PubMed ID: 11070094
[TBL] [Abstract][Full Text] [Related]
8. Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo.
Joel M; Mughal AA; Grieg Z; Murrell W; Palmero S; Mikkelsen B; Fjerdingstad HB; Sandberg CJ; Behnan J; Glover JC; Langmoen IA; Stangeland B
Mol Cancer; 2015 Jun; 14():121. PubMed ID: 26081429
[TBL] [Abstract][Full Text] [Related]
9. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand.
Ehtesham M; Kabos P; Gutierrez MA; Chung NH; Griffith TS; Black KL; Yu JS
Cancer Res; 2002 Dec; 62(24):7170-4. PubMed ID: 12499252
[TBL] [Abstract][Full Text] [Related]
10. Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression.
Shah K; Bureau E; Kim DE; Yang K; Tang Y; Weissleder R; Breakefield XO
Ann Neurol; 2005 Jan; 57(1):34-41. PubMed ID: 15622535
[TBL] [Abstract][Full Text] [Related]
11. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
Nakamizo A; Marini F; Amano T; Khan A; Studeny M; Gumin J; Chen J; Hentschel S; Vecil G; Dembinski J; Andreeff M; Lang FF
Cancer Res; 2005 Apr; 65(8):3307-18. PubMed ID: 15833864
[TBL] [Abstract][Full Text] [Related]
12. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.
Brown AB; Yang W; Schmidt NO; Carroll R; Leishear KK; Rainov NG; Black PM; Breakefield XO; Aboody KS
Hum Gene Ther; 2003 Dec; 14(18):1777-85. PubMed ID: 14670128
[TBL] [Abstract][Full Text] [Related]
13. Targeted-simultaneous expression of Gas1 and p53 using a bicistronic adenoviral vector in gliomas.
Benítez JA; Arregui L; Vergara P; Segovia J
Cancer Gene Ther; 2007 Oct; 14(10):836-46. PubMed ID: 17599090
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma.
Spencer D; Yu D; Morshed RA; Li G; Pituch KC; Gao DX; Bertolino N; Procissi D; Lesniak MS; Balyasnikova IV
Theranostics; 2019; 9(7):2071-2083. PubMed ID: 31037157
[TBL] [Abstract][Full Text] [Related]
15. Neural stem cells preferentially migrate to glioma stem cells and reduce their stemness phenotypes.
Zhang S; Xie R; Zhao T; Yang X; Han L; Ye F; Lei T; Wan F
Int J Oncol; 2014 Nov; 45(5):1989-96. PubMed ID: 25176161
[TBL] [Abstract][Full Text] [Related]
16. Polo-like kinase 1 inhibition kills glioblastoma multiforme brain tumor cells in part through loss of SOX2 and delays tumor progression in mice.
Lee C; Fotovati A; Triscott J; Chen J; Venugopal C; Singhal A; Dunham C; Kerr JM; Verreault M; Yip S; Wakimoto H; Jones C; Jayanthan A; Narendran A; Singh SK; Dunn SE
Stem Cells; 2012 Jun; 30(6):1064-75. PubMed ID: 22415968
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of neuronal nitric oxide synthase activity promotes migration of human-induced pluripotent stem cell-derived neural stem cells toward cancer cells.
Chen C; Wang Y; Goh SS; Yang J; Lam DH; Choudhury Y; Tay FC; Du S; Tan WK; Purwanti YI; Fan W; Wang S
J Neurochem; 2013 Aug; 126(3):318-30. PubMed ID: 23406356
[TBL] [Abstract][Full Text] [Related]
18. Novel Peripherally Derived Neural-Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas.
Birbrair A; Sattiraju A; Zhu D; Zulato G; Batista I; Nguyen VT; Messi ML; Solingapuram Sai KK; Marini FC; Delbono O; Mintz A
Stem Cells Transl Med; 2017 Feb; 6(2):471-481. PubMed ID: 28191774
[TBL] [Abstract][Full Text] [Related]
19. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model.
Ji XJ; Chen SH; Zhu L; Pan H; Zhou Y; Li W; You WC; Gao CC; Zhu JH; Jiang K; Wang HD
Oncol Rep; 2013 Jul; 30(1):157-64. PubMed ID: 23673813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
